Cite
HARVARD Citation
Omole, T. et al. (n.d.). P09 A Phase 2, randomized, double-blind study to evaluate the safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine (V116) in adults ≥50 years. JAC-antimicrobial resistance. p. . [Online].